HF
ORIC icon

HRT Financial’s Oric Pharmaceuticals ORIC Stock Holding History

HRT Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-102,583
Closed -$1.04M – 3512
2025
Q2 		$1.04M Buy
+102,583
New +$689K 0.01% 1251
2023
Q2 		– Sell
-126,147
Closed -$719K – 3062
2023
Q1 		$719K Buy
+126,147
New +$659K 0.01% 1146
2022
Q2 		– Sell
-46,446
Closed -$248K – 3555
2022
Q1 		$248K Buy
+46,446
New +$418K ﹤0.01% 2369
2021
Q2 		– Sell
-49,514
Closed -$1.21M – 3369
2021
Q1 		$1.21M Buy
+49,514
New +$1.56M 0.01% 953

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return